

31 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/31/3265529/0/en/Ambros-Therapeutics-Announces-Notice-of-Allowance-for-New-U-S-Patent-Application-Covering-Neridronate-for-Complex-Regional-Pain-Syndrome-Type-1.html

16 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ambros-therapeutics-launches-with-125-million-series-a-financing-to-advance-neridronate-through-phase-3-registrational-program-for-complex-regional-pain-syndrome-type-1-302642798.html